AI-Powered Protein Design
Readiness
TRL 4 · SRL 5 · gap -1
Gap = technical readiness − societal readiness. Positive: the technology is ready and society is not. Negative: society wants it more than the technology can deliver.
Not scored. Watchlist entries do not enter any gradient.
Generative models used to design proteins that do not exist in nature — specifying a shape or a function and producing a sequence that folds to it.
This is one of the genuinely significant developments in the Compendium and it is easy to miss because it is quiet. Protein structure prediction went from an open problem to a largely solved one within a few years, and design is the harder inverse of it. The output is enzymes for industrial processes, binders that attach to a chosen target, and vaccine components.
Technical readiness 4, and the scoring is fair: designed proteins are being made and tested, and the gap between a sequence that folds correctly in silico and a molecule that behaves in a body is exactly the gap that makes drug development slow. The model compresses the design step, which was never the decade-long part.
Common misconception: that this shortens drug timelines proportionately. It shortens discovery. Trials, manufacturing and approval are untouched, and they are most of the clock.
What it does
mechanism — not yet written. Published as missing rather than hidden.